Schiefke, Ingolf
University Hospitals Birmingham NHS Foundation Trust · Inserm · Université Paris Cité · Klinikum St. Georg · Sorbonne Université · University of Oxford · Centre de Recherche des Cordeliers · Centre de Recherche sur l'Inflammation · Physiopathologie et pharmacotoxicologie placentaire humaine : Microbiote pré & post natal · University of Birmingham · Newcastle University
6 papers on CoChat
Most cited papers
- Verified
A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis
Harrison, S. A., Bedossa, P., Guy, C. D., Schattenberg, J. M., Loomba, R., Taub, R., Labriola, D., Moussa, S. E., Neff, G. W., Rinella, M. E., et al. (2024) · New England Journal of Medicine
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 2,084
- Verified
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 1,277
- Verified
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Harrison, S. A., Wong, V. W.-S., Okanoue, T., Bzowej, N., Vuppalanchi, R., Younes, Z., Kohli, A., Sarin, S., Caldwell, S. H., Alkhouri, N., et al. (2020) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 497
- Verified
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
Ratziu, V., de Guevara, L., Safadi, R., Poordad, F., Fuster, F., Flores-Figueroa, J., Arrese, M., Fracanzani, A. L., Ben Bashat, D., Lackner, K., et al. (2021) · Nature Medicine
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 222
- Verified
Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection
Schiefke, I. (2005) · World Journal of Gastroenterology
Bone health and osteoporosis researchHepatitis C virus research
Cited by 156
- Verified
A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation
Yiannakou, Y., Piessevaux, H., Bouchoucha, M., Schiefke, I., Filip, R., Gabalec, L., Dina, I., Stephenson, D., Kerstens, R., Etherson, K., et al. (2015) · American Journal of Gastroenterology
Gastrointestinal motility and disordersPelvic floor disorders treatments
Cited by 104
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free